Zand Martin S, Bose Anirban, Vo Thuong, Coppage Myra, Pellegrin Tina, Arend Lois, Lee F Eun-Hyung, Bozorgzadeh Adel, Leong Nufatt
Nephrology Unit, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Am J Transplant. 2005 Jan;5(1):76-86. doi: 10.1111/j.1600-6143.2003.00637.x.
A major impediment to repetitive monitoring of alloreactivity or tolerance is the limited supply of donor cells available for assays of host-versus-graft T- and B-cell reactivity. In this paper, we describe the use of CD40L stimulated CD19(+) B cells as targets or stimulators in flow cytometric crossmatching (FXM), mixed lymphocyte reactivity and IFN-gamma ELISPOT assays. Stimulated B cells (sBc) express high levels of MHC class I and II, as well as the costimulatory molecules CD80 and CD86. They can be polyclonally expanded and frozen for later use. We describe the use of sBc in ELISPOT, mixed lymphocyte cultures and FXM. CD4(+) T cells exposed to sBc express a similar cytokine profile as those stimulated with unfractionated PBMC. We further analyzed T- and B-cell responses in 14 patients on the renal transplant waiting list, finding that those with an elevated panel reactive antibody (PRA) (>60%) had higher alloreactive T-cell precursor frequencies as measured by CDFSE MLR and IFN-gamma ELISPOT. We conclude that sBc are a renewable source of donor-specific target/stimulator cells for use in repetitive and coordinate assays of B- and T-cell alloreactivity.
重复监测同种异体反应性或耐受性的一个主要障碍是,可用于宿主抗移植物T细胞和B细胞反应性检测的供体细胞供应有限。在本文中,我们描述了使用CD40L刺激的CD19(+) B细胞作为流式细胞仪交叉配型(FXM)、混合淋巴细胞反应和IFN-γ ELISPOT检测中的靶细胞或刺激细胞。刺激的B细胞(sBc)表达高水平的MHC I类和II类分子,以及共刺激分子CD80和CD86。它们可以多克隆扩增并冷冻以备后用。我们描述了sBc在ELISPOT、混合淋巴细胞培养和FXM中的应用。暴露于sBc的CD4(+) T细胞表达的细胞因子谱与用未分离的外周血单个核细胞(PBMC)刺激的细胞相似。我们进一步分析了14例肾移植等待名单上患者的T细胞和B细胞反应,发现那些群体反应性抗体(PRA)升高(>60%)的患者,通过羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)混合淋巴细胞反应(MLR)和IFN-γ ELISPOT检测,其同种异体反应性T细胞前体频率更高。我们得出结论,sBc是一种可再生的供体特异性靶细胞/刺激细胞来源,可用于重复和协同检测B细胞和T细胞的同种异体反应性。